HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Hypohidrosis-diabetes insipidus syndrome — Clinical Guidelines

Overview

Hypohidrosis-diabetes insipidus syndrome encompasses conditions characterized by reduced sweating (hypohidrosis) and impaired water reabsorption leading to polyuria and polydipsia (diabetes insipidus). This syndrome can arise from various etiologies, including central and nephrogenic forms of diabetes insipidus, often complicating other clinical scenarios such as pregnancy and specific genetic mutations 1 5 12 24.

Diagnosis

Clinical Presentation: Polyuria, polydipsia, and in some cases, hypohidrosis 1.

Laboratory Tests:

- Water deprivation test to differentiate central from nephrogenic DI 7. - Measurement of serum osmolality and urine osmolality 7. - Vasopressin (ADH) levels and response to synthetic ADH (desmopressin) 8.

Imaging: MRI of the pituitary and hypothalamus to identify structural abnormalities 6 12.

Genetic Testing: Consider in cases with familial or suspected genetic etiology 24.

Management

Central DI:

- Desmopressin acetate (nasal spray, oral lyophilisate, or injectable) titrated to control polyuria 8.

Nephrogenic DI:

- Thiazide diuretics as first-line adjunctive therapy 7. - Monitoring and adjusting fluid intake to maintain hydration 7.

Supportive Care:

- Hydration management to prevent hypernatremia 1 7. - Regular monitoring of electrolytes and osmolality 7.

Special Populations

Pregnancy:

- Transient DI may occur, often associated with preeclampsia; manage with desmopressin (dDAVP) 19 20. - Altered osmoregulation can complicate diagnosis and management 13.

Pediatrics:

- Early recognition crucial in infants with cranial DI post-septic shock 15.

Elderly:

- Increased vigilance for complications like hypernatremia due to altered thirst mechanisms 13.

Comorbidities:

- Consider impact of conditions like HHV6 encephalitis on posterior pituitary function 6.

Key Recommendations

Utilize a water deprivation test combined with desmopressin response to accurately diagnose central vs. nephrogenic DI (Evidence: Moderate 7).

In pregnant women with transient DI, consider desmopressin for management, especially during preeclampsia (Evidence: Moderate 19 20).

Regular monitoring of electrolytes and osmolality is essential in all patients to prevent complications like hypernatremia (Evidence: Expert opinion).

Genetic testing should be considered in familial cases or suspected genetic mutations to guide management (Evidence: Weak 24).

References

1 Berton AM, Ferrante E, Razzore P. Challenges and unmet needs in diagnosing polyuria-polydipsia syndrome: National survey by the Italian Society of Endocrinology. Journal of endocrinological investigation 2026. link 2 Jacob AT, Kumar AH, Halivana G, Lukose L, Nair G, Subeesh V. Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. British journal of clinical pharmacology 2024. link 3 Castro-Dufourny I, Carrasco R, Prieto R, Pascual JM. Jean Camus and Gustave Roussy: pioneering French researchers on the endocrine functions of the hypothalamus. Pituitary 2017. link 4 Muyldermans M, Jennes S, Morrison S, Soete O, François PM, Keersebilck E et al.. Partial Nephrogenic Diabetes Insipidus in a Burned Patient Receiving Sevoflurane Sedation With an Anesthetic Conserving Device-A Case Report. Critical care medicine 2016. link 5 Qureshi S, Galiveeti S, Bichet DG, Roth J. Diabetes insipidus: celebrating a century of vasopressin therapy. Endocrinology 2014. link 6 Kawamoto S, Hatanaka K, Imakita M, Tamaki T. Central diabetes insipidus in an HHV6 encephalitis patient with a posterior pituitary lesion that developed after tandem cord blood transplantation. Internal medicine (Tokyo, Japan) 2013. link 7 Fenske W, Allolio B. Clinical review: Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. The Journal of clinical endocrinology and metabolism 2012. link 8 Vande Walle J, Stockner M, Raes A, Nørgaard JP. Desmopressin 30 years in clinical use: a safety review. Current drug safety 2007. link 9 Holcomb SS. Diabetes insipidus. Dimensions of critical care nursing : DCCN 2002. link 10 Kamsteeg EJ, Deen PM. Detection of aquaporin-2 in the plasma membranes of oocytes: a novel isolation method with improved yield and purity. Biochemical and biophysical research communications 2001. link 11 Odorizzi M, Max JP, Tankosic P, Burlet C, Burlet A. Dietary preferences of Brattleboro rats correlated with an overexpression of galanin in the hypothalamus. The European journal of neuroscience 1999. link 12 Masera N, Grant DB, Stanhope R, Preece MA. Diabetes insipidus with impaired osmotic regulation in septo-optic dysplasia and agenesis of the corpus callosum. Archives of disease in childhood 1994. link 13 Monson JP, Williams DJ. Osmoregulatory adaptation in pregnancy and its disorders. The Journal of endocrinology 1992. link 14 Krege J, Katz VL, Bowes WA. Transient diabetes insipidus of pregnancy. Obstetrical & gynecological survey 1989. link 15 Jenkins HR, Hughes IA, Gray OP. Cranial diabetes insipidus in early infancy. Archives of disease in childhood 1988. link 16 Knigge KM, Piekut DT, Berlove DJ, Junig JT, Melrose PA. Staining of magnocellular neurons of the supraoptic and paraventricular nuclei with vasopressin anti-idiotype antibody: a potential method for receptor immunocytochemistry. Brain research 1987. link90022-2) 17 Burlet AJ, Leon-Henri BP, Robert FR, Arahmani A, Fernette BM, Burlet CR. Monoclonal anti-vasopressin (VP) antibodies penetrate into VP neurons, in vivo. Experimental brain research 1987. link 18 Watkins WB. Use of a cross-species immunohistochemical procedure to demonstrate the presence of neurophysin antibodies in the serum of a patient treated with Pitressin. Neuroscience letters 1986. link90171-0) 19 Hadi HA, Mashini IS, Devoe LD. Diabetes insipidus during pregnancy complicated by preeclampsia. A case report. The Journal of reproductive medicine 1985. link 20 Korbet SM, Corwin HL, Lewis EJ. Transient nephrogenic diabetes insipidus associated with pregnancy. American journal of nephrology 1985. link 21 Hedge GA, Huffman LJ, Grunditz T, Sundler F. Immunocytochemical studies of the peptidergic innervation of the thyroid gland in the Brattleboro rat. Endocrinology 1984. link 22 Alonso G, Assenmacher I. Retrograde axoplasmic transport of neurosecretory material. An immunocytochemical and electron-microscopic study of transected axons in normal and colchicine-treated rats. Cell and tissue research 1983. link 23 Hime MC, Richardson JA. Diabetes insipidus and pregnancy. Case report, incidence and review of literature. Obstetrical & gynecological survey 1978. link 24 Schultz P, Lines DR. Nephrogenic diabetes insipidus in an Australian aboriginal kindred. Humangenetik 1975. link

Hypohidrosis-diabetes insipidus syndrome